Neurovalens raises £2.1M in funding and gains FDA approval for anxiety treatment wearable device
04/08/24, 2:48 PM
Location
belfastMoney raised
£2.1 million
Industry
medical device
medical
biotechnology
health care
Round Type
seed
Investors
Existing Investors
Belfast-based healthtech company Neurovalens announced that it has closed a £2.1 million funding round with existing investors and gained FDA approval for its Modius Stress device, designed to treat anxiety by delivering noninvasive electrical stimulation to the head.
Company Info
Location
belfast, northern ireland, united kingdom
Additional Info
Neurovalens is a healthtech company based in Belfast, specializing in combining neuroscience and technology to tackle global health challenges. It has developed medical devices designed to deliver noninvasive electrical stimulation to key areas of the brain and nervous system without the need for surgically implanted electrodes.